Business Standard

Sunday, December 22, 2024 | 06:36 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

TPG enters India's pharma market with $30 mn investment in Solara Active

TPG Growth's first investment in India focused on life sciences

rupee
Premium

Photo: Shutterstock

T E Narasimhan Chennai
TPG Growth will invest $30 million in Solara Active Pharma, a manufacturer of active pharmaceutical ingredients (API) with a network of clients including several global generic companies in the US and Europe.

The investment also marks TPG Growth’s first investment in India focused on life sciences.

Solara Active Pharma boasts operations and distribution in more than 40 countries, and manufacturing spread across five globally compliant facilities in India.

Shailesh Rao, Head of India for TPG Growth sai, “This investment will serve as a cornerstone of our growing efforts to invest in Indian life sciences.”

Rothschild (India) Private Limited acted as

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in